Skip to main content

Research Repository

Advanced Search

Pain relief after instrumented spinal surgery

Wilson, M. J.; Cole, A.; Hewson, D.; Hind, D.; Hawksworth, O.; Hyslop, M.; Keetharuth, A.; Macfarlane, A.; Martin, B.; Mcleod, G.; Rombach, I.; Swaby, L.; Tripathi, S.; Wilby, M.

Authors

M. J. Wilson

A. Cole

Dr DAVID HEWSON David.Hewson@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR IN ANAESTHETICS

D. Hind

O. Hawksworth

M. Hyslop

A. Keetharuth

A. Macfarlane

B. Martin

G. Mcleod

I. Rombach

L. Swaby

S. Tripathi

M. Wilby



Abstract

Background

Over 55,000 spinal operations are performed annually in the NHS. Effective postoperative analgesia facilitates early mobilisation and assists rehabilitation and hospital discharge, but is difficult to achieve with conventional, opioid-based, oral analgesia. The clinical and cost-effectiveness of two alternative techniques, namely intrathecal opioid and the more novel erector-spinae plane blockade, is unknown. The Pain Relief After Instrumented Spinal Surgery (PRAISE) trial aims to evaluate these techniques.

Methods

PRAISE is a multicentre, prospective, parallel group, patient-blinded, randomised trial, seeking to recruit 456 adult participants undergoing elective, posterior lumbar-instrumented spinal surgery from up to 25 NHS hospitals. Participants will be randomised 1:1:1 to receive (1) Usual Care with local wound infiltration, (2) Intrathecal Opioid plus Usual Care with local wound infiltration or (3) Erector Spinae Plane blockade plus Usual Care with no local wound infiltration. The primary outcome is pain on movement on a 100mm visual analogue scale at 24 hours post-surgery. Secondary outcomes include pain at rest, leg pain, quality of recovery (QoR-15), postoperative opioid consumption, time to mobilisation, length of hospital stay, health utility (EQ-5D-5L), adverse events and resource use. Parallel economic evaluation will estimate incremental cost-effectiveness ratios.

Results

Differences in the primary outcome at 24 hours will be estimated by mixed-effects linear regression modelling, with fixed effects for randomisation factors and other important prognostic variables, and random effects for centre, using the as-randomised population. Treatment effects with 95% confidence intervals will be presented.

Conclusion

The study is due to open in May 2024 and complete in 2026.

Conflicts of Interest

No conflicts of interest declared

Sources of Funding

NIHR Health Technology Award – grant number NIHR153170

Trial presentations so far

APOMP 2023 and 2024; RCOA conference, York, November 2023; Faculty of Pain Management training day, London, February 2024.

Citation

Wilson, M. J., Cole, A., Hewson, D., Hind, D., Hawksworth, O., Hyslop, M., Keetharuth, A., Macfarlane, A., Martin, B., Mcleod, G., Rombach, I., Swaby, L., Tripathi, S., & Wilby, M. (2024, June). Pain relief after instrumented spinal surgery. Presented at The Society for Back Pain Research (SBPR) 2024 Annual General Meeting: “Innovation in Research and Management of Spine Pain”, Aberdeen, Scotland

Presentation Conference Type Conference Abstract
Conference Name The Society for Back Pain Research (SBPR) 2024 Annual General Meeting: “Innovation in Research and Management of Spine Pain”
Start Date Jun 13, 2024
End Date Jun 14, 2024
Online Publication Date Aug 7, 2024
Publication Date Aug 7, 2024
Deposit Date May 29, 2025
Journal Orthopaedic Proceedings
Print ISSN 1358-992X
Electronic ISSN 2049-4416
Publisher British Editorial Society of Bone and Joint Surgery
Peer Reviewed Peer Reviewed
Volume 106-B
Issue SUPP_15
Pages 37
DOI https://doi.org/10.1302/1358-992X.2024.15.037
Public URL https://nottingham-repository.worktribe.com/output/49558477
Publisher URL https://boneandjoint.org.uk/Article/10.1302/1358-992X.2024.15.037